Last reviewed: July 2, 2026
Last updated: July 2, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active compound in Wegovy and Ozempic, works by slowing gastric emptying and activating GLP-1 receptors throughout the body. Clinical trials show A1C reductions of 1.5–2.5% alongside significant weight loss in people with type 2 diabetes and obesity. PlexusDx provides access to compounded semaglutide injections for metabolic health support at a flat monthly rate.
How Semaglutide Reduces A1C and Blood Sugar
Semaglutide lowers blood glucose by stimulating insulin release when blood sugar rises, then suppressing glucagon secretion when levels drop. This dual mechanism prevents both hyperglycemia and dangerous drops, stabilizing A1C over weeks and months. Research in the SUSTAIN trial series documented A1C reductions averaging 1.8% in adults with type 2 diabetes taking semaglutide weekly.
The medication also improves insulin sensitivity in muscle and liver cells, meaning the body's own insulin works more effectively. This addresses the root cause of high A1C rather than forcing insulin production. Many patients on semaglutide see A1C improvements within 4–8 weeks of consistent dosing.
Weight Loss Mechanisms and Metabolic Effects
Semaglutide reduces appetite by activating GLP-1 receptors in the hypothalamus, the brain's hunger control center. It simultaneously slows how fast the stomach empties food, extending feelings of fullness and reducing overall calorie intake. In pivotal trials, participants lost 10–15% of body weight over 68 weeks, with some achieving 20% or greater reductions.
Beyond appetite suppression, semaglutide improves how the body uses energy and may increase fat oxidation during physical activity. These metabolic shifts help preserve muscle while fat loss occurs, supporting long-term weight management and cardiovascular health. The combination of lower A1C and sustained weight loss reduces diabetes progression and heart disease risk.
Clinical Evidence: A1C and Weight Loss Together
The SUSTAIN-5 trial showed that participants on semaglutide 1.0 mg weekly achieved mean A1C reductions of 1.5% while losing an average of 3.5 kg, and those on 1.7 mg lost 5.2 kg with similar glycemic control. This dual benefit is rare—most weight loss medications don't lower A1C, and most diabetes medications cause weight gain. Semaglutide's effect on both pathways makes it uniquely effective for metabolic syndrome.
Long-term follow-up studies confirm that A1C reductions persist beyond one year, and weight loss stabilizes at a new baseline when dosing is maintained. Discontinuation studies show that both A1C and weight begin to return to baseline within weeks, demonstrating the medication's ongoing need for sustained benefit. This evidence underpins why many endocrinologists recommend semaglutide as a foundational therapy for type 2 diabetes and obesity together.
PlexusDx Compounded Semaglutide vs. Brand-Name Options
PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies, meeting the same pharmaceutical standards as branded Wegovy and Ozempic. The compounded form is chemically identical and works through the same GLP-1 receptor pathway. PlexusDx charges a flat monthly rate starting at $149/mo—your dose may need to go up, but your price won't.
Unlike brand-name medications requiring insurance approval or out-of-pocket costs exceeding $900–$1,500 monthly, PlexusDx serves all 50 states with no insurance requirement, no membership fee, and HSA/FSA eligibility. Many patients access compounded semaglutide within days rather than weeks of enrollment. For people seeking affordable, accessible metabolic support, PlexusDx compounded semaglutide delivers clinical-grade treatment at transparent pricing.
Personalized Treatment with Precision Peptide Genetic Testing
Not everyone responds to semaglutide identically. PlexusDx offers the Precision Peptide Genetic Test—a peptide-pathway genetic analysis that identifies variants in GLP1R, GIPR, FTO, and MC4R, genes influencing how your body processes and responds to GLP-1 therapy. This test maps 14 metabolic pathways and 150+ genetic insights to guide dose optimization and medication selection.
Patients with specific GLP1R rs6923761 variants, for example, may achieve A1C and weight loss goals faster or require different dosing strategies. The genetic test costs $99 as an add-on after the first month of treatment, enabling PlexusDx to personalize your protocol. This precision approach increases the likelihood of sustained A1C control and weight management success.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does semaglutide really lower A1C if I don't have diabetes?
Semaglutide improves fasting blood glucose and insulin sensitivity even in people without type 2 diabetes, helping prevent prediabetes progression. However, the most dramatic A1C reductions occur in people with diagnosed diabetes or prediabetes. PlexusDx evaluates each patient's metabolic profile to determine if semaglutide aligns with individual health goals.
How long does it take to see A1C improvements on semaglutide?
Most patients see measurable A1C reductions within 4–8 weeks of consistent weekly dosing. Full benefit typically emerges by 12–16 weeks as steady-state blood levels build. Your healthcare provider will check A1C every 3 months to track progress and adjust dosing if needed.
Can I use PlexusDx semaglutide if my insurance doesn't cover it?
Yes—PlexusDx serves all 50 states with no insurance requirement. Compounded semaglutide starts at $149/mo, and coverage is HSA/FSA eligible. No membership fees apply, and pricing remains flat regardless of dose adjustments.
What happens to my A1C and weight if I stop semaglutide?
A1C and weight typically begin returning to baseline within 2–4 weeks of discontinuation, with full reversal occurring over several months. This underscores why consistent, long-term treatment is important for sustained metabolic benefit. Discuss any dosing changes or pauses with your PlexusDx healthcare provider first.
How does the Precision Peptide Genetic Test improve my results?
The test identifies your genetic predispositions in GLP-1 signaling and appetite regulation, allowing PlexusDx to predict your response to semaglutide and optimize starting dose and escalation. Variants like GLP1R rs6923761 influence medication efficacy, potentially shortening your time to A1C goal by weeks or months. Results cost $99 and are available after your first month of treatment.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Blurry Vision a Side Effect of Ozempic?
What Is the Best Spot to Inject Ozempic for Effective Weight Management?